EVHHIGH SIGNALFINANCIAL10-K

EVH experienced a massive deterioration in profitability with net losses expanding from -$20.9M to -$534.5M while operating cash flow improved and the company reduced share count and total assets.

The dramatic 2,462% increase in net losses combined with a 913% deterioration in operating income suggests either major one-time charges, significant operational challenges, or both. However, the simultaneous improvement in operating cash flow and reduction in share count from 116.6M to 111.6M indicates potential restructuring or asset rationalization efforts that may position the company for future improvement.

Comparing 2026-02-25 vs 2025-02-21View on EDGAR →
FINANCIAL ANALYSIS

EVH's financial profile shows a tale of two narratives - catastrophic P&L performance with net losses ballooning to -$534.5M and interest expense tripling, yet improved operational cash generation (+107% to $38.8M) and a stronger cash position (+45.7% to $151.9M). The company appears to have undergone significant downsizing with total assets declining 25.4% to $1.9B, receivables falling 25.3%, and current liabilities dropping 46.2%, while stockholders' equity was cut nearly in half to $415.2M. This combination suggests major restructuring charges or impairments hit earnings while underlying cash generation and balance sheet management improved, creating a complex investment picture requiring deeper analysis of the nature of the losses.

FINANCIAL STATEMENT CHANGES
Net Income
P&L
-2461.9%
-$20.9M-$534.5M

Net income declined 2461.9% — review whether driven by operations, interest costs, or non-recurring items.

Operating Income
P&L
-913.1%
-$40.5M-$410.1M

Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.

Interest Expense
P&L
+248.1%
$15.6M$54.2M

Interest expense surged 248.1% — significant debt increase or rising rates materially impacting earnings.

Operating Cash Flow
Cash Flow
+107%
$18.8M$38.8M

Operating cash flow surged 107% — exceptional cash generation, highest quality earnings signal.

Stockholders Equity
Balance Sheet
-58.5%
$1.0B$415.2M

Equity declined sharply — large losses, buybacks, or write-downs reducing book value significantly.

Current Liabilities
Balance Sheet
-46.2%
$715.5M$385.3M

Current liabilities reduced — improved short-term financial position and working capital health.

Cash & Equivalents
Balance Sheet
+45.7%
$104.2M$151.9M

Cash position surged 45.7% — strong cash generation or capital raise providing significant financial cushion.

Total Debt
Balance Sheet
+32.9%
$221.0M$293.7M

Debt increased 32.9% — substantial leverage increase; assess whether deployed for growth or covering losses.

Total Assets
Balance Sheet
-25.4%
$2.5B$1.9B

Total assets contracted 25.4% — asset sales, write-downs, or balance sheet optimization underway.

Accounts Receivable
Balance Sheet
-25.3%
$414.7M$309.9M

Receivables declined — improved collection efficiency or conservative revenue recognition.

LANGUAGE CHANGES
NEW — 2026-02-25
PRIOR — 2025-02-21
ADDED
As of February 16, 2026, there were 111,638,338 shares of the registrant s Class A common stock outstanding.
Management s Discussion and Analysis of Financial Condition and Results of Operations 42 7A.
Changes in and Disagreements With Accountants on Accounting and Financial Disclosure 108 9A.
Our acquisitions have been focused on companies with extensive experience assisting customers in managing the large and complex specialties of oncology, cardiology, radiology, musculoskeletal, physical medicine, and genetics care.
We have one operating segment and one reportable segment as our chief operating decision maker ( CODM ), who is our Chief Executive Officer, assesses the performance of our operations, develops strategy and reviews financial information on a consolidated basis for purposes of evaluating financial performance and allocating resources.
+7 more — sign up free →
REMOVED
As of February 14, 2025, there were 116,591,148 shares of the registrant s Class A common stock outstanding.
Management s Discussion and Analysis of Financial Condition and Results of Operations 47 7A.
Changes in and Disagreements With Accountants on Accounting and Financial Disclosure 115 9A.
In October 2021, we acquired Vital Decisions, a leading provider of technology-enabled advance care planning services.
In August 2022, we acquired IPG, a leader in providing surgical management solutions for musculoskeletal conditions.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
PNRGHIGHPNRG achieved exceptional profitability improvement with net income surging 2,21...
2026-04-16
BNAIHIGHBNAI underwent a dramatic reverse stock split that reduced share count by 86% wh...
2026-04-16
LAKEHIGHLAKE's financial performance deteriorated significantly with operating losses wo...
2026-04-16
NXXTHIGHNextNRG experienced massive financial deterioration with operating losses explod...
2026-04-16
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →